Similar articles

• Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.

  Ding J, Sun D, Xie P. Ding J, et al. Biosci Rep. 2019 Jun 25;39(6):BSR20182214. doi: 10.1042/BSR20182214. Print 2019 Jun 28. Biosci Rep. 2019. Retraction in: Biosci Rep. 2022 Nov 30;42(11):BSR-2018-2214_RET. doi: 10.1042/BSR-2018-2214_RET. PMID: 31138758 Free PMC article. Retracted.
• Expression of Concern: Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.

  [No authors listed] [No authors listed] Biosci Rep. 2022 Sep 30;42(9):BSR-2018-2214_EOC. doi: 10.1042/BSR-2018-2214_EOC. Biosci Rep. 2022. PMID: 36156069 Free PMC article. No abstract available.
• MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.

  Chen HX, Xu XX, Tan BZ, Zhang Z, Zhou XD. Chen HX, et al. Cell Physiol Biochem. 2017;41(3):933-946. doi: 10.1159/000460510. Epub 2017 Feb 20. Cell Physiol Biochem. 2017. PMID: 28222438
• Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review.

  Najafi M, Ahmadi A, Mortezaee K. Najafi M, et al. Cell Biol Int. 2019 Nov;43(11):1206-1222. doi: 10.1002/cbin.11187. Epub 2019 Jul 11. Cell Biol Int. 2019. PMID: 31136035 Review.
• Human DNA Virus Exploitation of the MAPK-ERK Cascade.

  DuShane JK, Maginnis MS. DuShane JK, et al. Int J Mol Sci. 2019 Jul 12;20(14):3427. doi: 10.3390/ijms20143427. Int J Mol Sci. 2019. PMID: 31336840 Free PMC article. Review.